arXiv Science⌕ Search
Home/Archive/arXiv

arXiv · 2507.15685

The Win Ratio at the Design Stage of Clinical Trials

David Kronthaler·Matthias Schwenkglenks·Felix Beuschlein·Ulrike Held
View original source ↗Read source document ↗Export metadata ↓

Abstract

The win ratio offers a flexible approach to incorporate the hierarchy of clinical outcomes into the analysis of a composite endpoint, enabling simultaneous consideration of multiple outcome types, unlike traditional time-to-first-event (TTFE) analysis or focus on a single outcome. We examined the statistical power of the win ratio compared to single-endpoint analyses and TTFE analysis through a case study and simulation studies. Furthermore, we provide a novel formula to estimate the required sample size for win ratio analysis based on the desired width of its confidence interval, facilitating precision-based trial design. Our results indicate that win ratio analysis generally outperforms single-endpoint analyses when treatment effects on lower-ranked outcomes are moderate compared to those on higher-ranked outcomes. The win ratio can provide greater power than TTFE analysis, especially when the effect on the highest-ranked outcome is substantial, reaching increases in power up to 50\%. Further, even for moderate treatment effects on the highest-ranked outcome, win ratio analysis achieved higher power. Future work should expand our simulations to additional data-generating mechanisms and outcome types, particularly ordinal outcomes, where the win ratio provides an alternative to existing non-parametric and parametric methods. Our findings highlight the potential of the win ratio to improve statistical efficiency in pharmaceutical and other clinical trial designs using composite endpoints, particularly when no single component dominates the treatment effect. However, when continuous outcomes occupy the top of the hierarchy, these tend to drive overall analysis, sidelining contributions of lower-ranked outcomes and limiting benefits of hierarchical win ratio analysis.

Explore related subjects

stat.ME

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

David Kronthaler, Matthias Schwenkglenks, Felix Beuschlein, Ulrike Held. 2025-07-21. The Win Ratio at the Design Stage of Clinical Trials. https://arxiv.org/abs/2507.15685

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

arXiv2026

Generalised Covariances and Correlations

The covariance of two random variables measures the average joint deviations from their respective means. We generalise this well-known measure by replacing the means with other statistical functionals such as quantiles, expectiles, or thresholds. Deviations from these functionals are defined via generalised errors, typically induced through identification or moment functions. As a normalised measure of dependence, a generalised correlation is constructed. Replacing the common Cauchy--Schwarz normalisation by a novel Fréchet--Hoeffding normalisation, we obtain attainability of the entire interval $[-1, 1]$ for any given marginal distributions. We uncover favourable properties of these new dependence measures and establish consistent estimators. The families of quantile and threshold correlations make it possible to measure local dependence and give rise to function-valued distributional correlations, exhibiting the entire dependence structure. Quantile correlations also lead to tail correlations, new measures of tail dependence, closely related to and refining classical coefficients of tail dependence. Finally, we construct summary covariances (correlations), a class of regional or global dependence measures, which arise as (normalised) weighted averages of distributional covariances. We retrieve covariance, Pearson and Spearman correlation as special cases. The usefulness of our new dependence measures is illustrated on demographic data from the Panel Study of Income Dynamics.

stat.ME↗
arXiv2026

Compressive Bayesian non-negative matrix factorization for mutational signatures analysis

Non-negative matrix factorization (NMF) is a popular tool for dimensionality reduction, especially for count matrices. However, inferring an appropriate number of factors is challenging. Existing approaches based on information criteria or nonparametric sparsity-inducing priors tend to be computationally burdensome or highly sensitive to prior choices. Moreover, theoretical properties of the posterior distribution of Poisson NMF parameters endowed with shrinkage priors remain under-explored. This paper introduces a novel Bayesian NMF method that automatically infers the number of factors while also incorporating information on the latent factors from previous studies. This is achieved using compressive hyperpriors, which are hierarchical priors that make the sample-specific weights of unneeded factors concentrate near zero in the posterior. We provide novel distribution theory for posterior inference to elucidate this shrinkage mechanism, both in finite samples and asymptotically. We apply our method to mutational signatures analysis in cancer genomics, in simulations and on real data from breast cancer. Compared to state-of-the-art alternatives, our method is more robust to mild overdispersion and improves detection and estimation of signatures aligned with prior information.

stat.ME↗
arXiv2026

On Relative Cumulative Residual Information Measure and Its Applications

We develop a relative cumulative residual information measure (RCRI) that aims to quantify the divergence between two survival functions. The dynamic relative cumulative residual information (DRCRI) measure is also introduced. We establish some characterization results under the assumption of the proportional hazards model. Additionally, we obtained the non-parametric estimators of RCRI and DRCRI measures based on the kernel density type estimator for the survival function. The effectiveness of the estimators are assessed through an extensive Monte Carlo simulation study. We consider data from the third Gaia data release (Gaia DR3) to demonstrate the use of the proposed measure. For this study, we have collected epoch photometry data for the objects Gaia DR3 4111834567779557376 and Gaia DR3 5090605830056251776. RCRI-based image analysis is conducted using Chest X-ray data from the publicly available dataset.

stat.ME↗